Expression of the Epstein-Barr virus gp350/220 gene in rodent and primate cells

Authors:
  • YWY Whang
    Y Whang
  • MSM Silberklang
    M Silberklang
  • AMA Morgan
    A Morgan
  • SMS Munshi
    S Munshi
  • ALA B Lenny
    A B Lenny
  • RER W Ellis
    R W Ellis
  • EKE Kieff
    E Kieff

Abstract
The gene encoding the Epstein-Barr virus envelope glycoproteins gp350 and gp220 was inserted downstream of the cytomegalovirus immediate-early, Moloney murine leukemia virus, mouse mammary tumor virus, or varicella-zoster virus gpI promoters in vectors containing selectable markers. Host cell and recombinant vector systems were defined which enabled the isolation of rodent or primate cell clones which expressed gp350/220 in substantial quantities. Continued expression of gp350/220 required maintenance of cells under positive selection for linked markers and periodic cloning. gp350/220 expressed in various host cells varied slightly in electrophoretic mobility, probably reflecting differences in glycosylation. Insertion of a stop codon into the gp350/220 open reading frame, upstream of the putative membrane anchor sequence, resulted in efficient secretion of truncated gp350 and gp220 from rat pituitary (GH3) cells. gp350/220 expressed in mammalian cells is highly immunogenic and elicits virus-neutralizing antibodies when administered to mice. Images

This publication has 59 references indexed in Scilit: